Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prothena Corp Public (PRTA) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Prothena Corp Public (PRTA) over the last 13 years, with Q3 2025 value amounting to -$23000.0.

  • Prothena Corp Public's Other Non Operating Income rose 6515.15% to -$23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$297000.0, marking a year-over-year increase of 2556.39%. This contributed to the annual value of -$185000.0 for FY2024, which is 5960.7% up from last year.
  • Prothena Corp Public's Other Non Operating Income amounted to -$23000.0 in Q3 2025, which was up 6515.15% from -$143000.0 recorded in Q2 2025.
  • Over the past 5 years, Prothena Corp Public's Other Non Operating Income peaked at $23000.0 during Q1 2021, and registered a low of -$327000.0 during Q4 2022.
  • In the last 5 years, Prothena Corp Public's Other Non Operating Income had a median value of -$61000.0 in 2021 and averaged -$75894.7.
  • In the last 5 years, Prothena Corp Public's Other Non Operating Income skyrocketed by 19583.33% in 2021 and then tumbled by 475000.0% in 2023.
  • Quarter analysis of 5 years shows Prothena Corp Public's Other Non Operating Income stood at -$16000.0 in 2021, then plummeted by 1943.75% to -$327000.0 in 2022, then surged by 37.31% to -$205000.0 in 2023, then surged by 104.39% to $9000.0 in 2024, then tumbled by 355.56% to -$23000.0 in 2025.
  • Its Other Non Operating Income stands at -$23000.0 for Q3 2025, versus -$143000.0 for Q2 2025 and -$140000.0 for Q1 2025.